Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Accumulated Expenses (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Accumulated Expenses for 16 consecutive years, with $3.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses fell 38.55% year-over-year to $3.9 million, compared with a TTM value of $3.9 million through Sep 2025, down 38.55%, and an annual FY2024 reading of $6.3 million, down 12.23% over the prior year.
  • Accumulated Expenses was $3.9 million for Q3 2025 at Rockwell Medical, down from $4.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.7 million in Q4 2022 and bottomed at $3.8 million in Q2 2023.
  • Average Accumulated Expenses over 5 years is $5.2 million, with a median of $4.7 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses soared 63.91% in 2024, then tumbled 38.55% in 2025.
  • Year by year, Accumulated Expenses stood at $5.1 million in 2021, then soared by 51.32% to $7.7 million in 2022, then decreased by 7.18% to $7.1 million in 2023, then decreased by 12.23% to $6.3 million in 2024, then crashed by 38.41% to $3.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for RMTI at $3.9 million in Q3 2025, $4.1 million in Q2 2025, and $4.6 million in Q1 2025.